N
Nassim Kamar
Researcher at Paul Sabatier University
Publications - 696
Citations - 25605
Nassim Kamar is an academic researcher from Paul Sabatier University. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 73, co-authored 628 publications receiving 20442 citations. Previous affiliations of Nassim Kamar include French Institute of Health and Medical Research & Tabriz University of Medical Sciences.
Papers
More filters
Journal ArticleDOI
Hepatitis E virus and chronic hepatitis in organ-transplant recipients.
Nassim Kamar,Janick Selves,Jean-Michel Mansuy,Leila Ouezzani,Jean-Marie Péron,Joelle Guitard,Olivier Cointault,Laure Esposito,Florence Abravanel,Marie Danjoux,Dominique Durand,Jean-Pierre Vinel,Jacques Izopet,Lionel Rostaing +13 more
TL;DR: The time from transplantation to diagnosis was significantly shorter and the total counts of lymphocytes and of CD2, CD3, and CD4 T cells were significantly lower in patients in whom chronic disease developed.
Journal ArticleDOI
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
TL;DR: Three Covid-19 Vaccine Doses in Transplant Recipients Solid-organ transplant recipients receiving immunosuppressive therapy appear to have a poor response to Covid19 vaccination as mentioned in this paper.
Journal ArticleDOI
Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants.
Nassim Kamar,Nassim Kamar,Cyril Garrouste,Elizabeth B. Haagsma,Valérie Garrigue,Sven Pischke,Cecile Chauvet,Jérôme Dumortier,Amelie Cannesson,Elisabeth Cassuto-Viguier,Eric Thervet,Filomena Conti,Pascal Lebray,Harry R. Dalton,Robert N. Santella,Nada Kanaan,Marie Essig,Christiane Mousson,Sylvie Radenne,Anne Marie Roque-Afonso,Jacques Izopet,Jacques Izopet,Lionel Rostaing,Lionel Rostaing +23 more
TL;DR: A retrospective analysis of data from 17 centers from Europe and the United States that described the progression, outcomes, and factors associated with development of chronic HEV infection in recipients of transplanted solid organs found tacrolimus therapy is the main predictive factor for chronic hepatitis.
Journal ArticleDOI
Hepatitis E Virus Infection
Nassim Kamar,Nassim Kamar,Harry R. Dalton,Florence Abravanel,Florence Abravanel,Jacques Izopet,Jacques Izopet +6 more
TL;DR: In this comprehensive review, the current knowledge about the virus itself, as well as the epidemiology, diagnostics, natural history, and management of HEV infection in developing and developed countries are summarized.
Journal ArticleDOI
Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients
Nassim Kamar,Jacques Izopet,Simona Tripon,Michael Bismuth,Sophie Hillaire,Jérôme Dumortier,Sylvie Radenne,Audrey Coilly,Valérie Garrigue,Louis d’Alteroche,Matthias Büchler,Lionel Couzi,Pascal Lebray,Sébastien Dharancy,Anne Minello,Maryvonne Hourmant,Anne-Marie Roque-Afonso,Florence Abravanel,Stanislas Pol,Lionel Rostaing,Vincent Mallet +20 more
TL;DR: This retrospective, multicenter study showed that ribavirin as monotherapy may be effective in the treatment of chronic HEV infection; a 3-month course seemed to be an appropriate duration of therapy for most patients.